Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-08-02

Clinical Trial Update: Nerve Rerouting Treatment for Neurogenic Bladder in Spina Bifida [NA]

View source ↗

Summary

A clinical trial investigating a nerve rerouting treatment for neurogenic bladder in individuals with Spina bifida has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kenneth Peters, MD | Conditions: Spina Bifida | NA | Status: WITHDRAWN